Andrew Reardon, Chief Legal Officer &: Ligand Pharmaceuticals LGND Sell · Filed 24/05/13

Trade details

Type: Insider sale
Amount: $830,400
Shares · price: 10,000 sh · $83.04 a share
Held after: 22,205 sh
Stock: Ligand Pharmaceuticals LGND
Person: Andrew ReardonChief Legal Officer &
Trade date: 24/05/09
Filed: 24/05/13
Days to filing: 4 days

Sold 31.1% of holdings

Share of holding sold: 31.1%

Ligand Pharmaceuticals trades, last 26 weeks

What else happened in Ligand Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/09~24/06/08

Andrew Reardon's recent trades

Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$4.3M
15,000 sh
$4.3M
Filed 09/03
Traded 09/03
Andrew ReardonCLO & Secretary
Planned sale10b5-1 planLigand Pharmaceuticals
Planned sale10b5-1 plan
Ligand Pharmaceuticals
LGND
$3.2M
10,000 sh
$3.2M
Filed 07/01
Traded 07/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$323.6K
1,432 sh
$323.6K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$279K
1,216 sh
$279K
Filed 06/02
Traded 06/01
Andrew ReardonCLO & Secretary
Sell10b5-1 planLigand Pharmaceuticals
Sell10b5-1 plan
Ligand Pharmaceuticals
LGND
$152.5K
677 sh
$152.5K
Filed 06/02
Traded 06/01

Andrew Reardon, CLO — sold $830.4K of Ligand Pharmaceuticals LGND · 31.1% of holdings | Whalegun